Skip to main content
David Hockenbery, MD, Gastroenterology, Seattle, WA

DavidMHockenberyMD

Gastroenterology Seattle, WA

Head, Gastroenterology/Hepatology Division

Dr. Hockenbery is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Hockenbery's full profile

Already have an account?

  • Office

    825 Eastlake Ave E
    Seattle, WA 98109
    Phone+1 206-288-1000
    Fax+1 206-598-6963

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Gastroenterology, 1986 - 1992
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 1982 - 1985
  • Washington University in St. Louis School of Medicine
    Washington University in St. Louis School of MedicineClass of 1982

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 1992 - 2027
  • MD State Medical License
    MD State Medical License 1985 - 1986
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 2002

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Pan-Cancer Transcriptional Signatures Predictive of Oncogenic Mutations Reveal That Fbw7 Regulates Cancer Cell Oxidative Metabolism  
    David M Hockenbery, Bruce E Clurman, Proceedings of the National Academy of Sciences

Press Mentions

  • Dr. David M. Hockenbery, Recipient of the 2022 Dr. Ali Al-Johani Award
    Dr. David M. Hockenbery, Recipient of the 2022 Dr. Ali Al-Johani AwardMarch 15th, 2022
  • Can a Tumor That Acts like a Microbe Help Us Develop Better Cancer Therapies?
    Can a Tumor That Acts like a Microbe Help Us Develop Better Cancer Therapies?August 6th, 2020
  • How a Phone Call Helped Shape the Field of Bone Marrow Transplant
    How a Phone Call Helped Shape the Field of Bone Marrow TransplantJanuary 30th, 2019

Grant Support

  • Metabolism, Protein And Mirna Cross-Talk In Cell Cycle And Tumor ProgressionNational Cancer Institute2012
  • Biomarker Discovery For Mitochondrial Toxicants Using Metabolic FootprintingNational Institute Of Environmental Health Sciences2011
  • Metabolic Alterations In Advanced Breast Cancer And Response To Systemic Therapy.National Cancer Institute2010–2011
  • Mechanisms Linking Nutrient Supply &Cell Cycle/SurvivalNational Cancer Institute2008–2009
  • Cell Metabolism And MYC Induced Growth, Death, And NeoplasiaNational Cancer Institute2007–2009
  • Regulation Of Substrate-Linked Mitochondrial ROS GenerationNational Cancer Institute2006–2007
  • Cell Metabolism &Myc Induced Growth Death, &NeoplasiaNational Cancer Institute2006
  • Cell Metabolism &Myc Induced Growth, Death, &NeoplasiaNational Cancer Institute2005
  • Small Molecule Inhibitors Of BCI XL Survival ProteinNational Cancer Institute2001–2004
  • Mitochondrial Control Of Intestinal ApoptosisNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2004
  • Role Of BCL 2 Related Genes In HematopoiesisNational Heart, Lung, And Blood Institute1997–1999
  • Apoptotic Pathways In B Lymphocyte ActivationNational Institute Of General Medical Sciences1997
  • Apoptosis And The Epidemiology Of Breast CancerNational Cancer Institute1995–1996